Prodotto aggiunto correttamente al carrello.

discount label
H-IMYNYPAM-OH
Visualizzare in 3D

Biosynth logo

H-IMYNYPAM-OH

Rif. 3D-PP44770

1mg
202,00 €
10mg
234,00 €
100mg
412,00 €
Consegna stimata in Stati Uniti, il Venerdì 27 Dicembre 2024

Informazioni sul prodotto

Nome:
H-IMYNYPAM-OH
Sinonimi:
  • NH2-Ile-Met-Tyr-Asn-Tyr-Pro-Ala-Met-OH
Descrizione:

Peptide H-IMYNYPAM-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-IMYNYPAM-OH include the following: Photochemically-Mediated Inflammation and Cross-Presentation of Mycobacterium bovis BCG Proteins Stimulates Strong CD4 and CD8 T-Cell Responses in Mice Y Waeckerle-Men, ZK Kotkowska, G Bono - Frontiers in , 2022 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fimmu.2022.815609/full Distinct Differences in the Expansion and Phenotype of TB10.4 Specific CD8 and CD4 T Cells after Infection with Mycobacterium tuberculosis TTKT Hoang, A Nansen, S Roy, R Billeskov - PloS one, 2009 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0005928 High-frequency vaccine-induced CD8+ T cells specific for an epitope naturally processed during infection with Mycobacterium tuberculosis do not confer protection T Lindenstrom , C Aagaard - European journal of , 2014 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.201344358 Rational design and in vivo characterization of vaccine adjuvants ST Schmidt, GK Pedersen , D Christensen - ILAR journal, 2018 - academic.oup.comhttps://academic.oup.com/ilarjournal/article-abstract/59/3/309/5281128 A natural polymorphism of Mycobacterium tuberculosis in the esxH gene disrupts immunodomination by the TB10.4-specific CD8 T cell response R Sutiwisesak , ND Hicks , S Boyce, KC Murphy - PLoS , 2020 - journals.plos.orghttps://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1009000 Natural Polymorphism of Mycobacterium tuberculosis and CD8 T Cell Immunity R Sutiwisesak - 2020 - repository.escholarship.umassmed https://repository.escholarship.umassmed.edu/handle/20.500.14038/31300 Extensive major histocompatibility complex class I binding promiscuity for Mycobacterium tuberculosis TB10.4 peptides and immune dominance of human leucocyte antigen R Axelsson-Robertson, F Weichold, D Sizemore - , 2010 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/j.1365-2567.2009.03201.x Recombinant Pichinde viral vector expressing tuberculosis antigens elicits strong T cell responses and protection in mice NM Kirk, Q Huang , S Vrba , M Rahman - Frontiers in , 2023 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fimmu.2023.1127515/full Induction of CD8+ T-cell responses against subunit antigens by the novel cationic liposomal CAF09 adjuvant KS Korsholm, J Hansen, K Karlsen, J Filskov - Vaccine, 2014 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X14007269 Mycobacterium tuberculosis-specific CD4+ and CD8+ T cells differ in their capacity to recognize infected macrophages JD Yang, D Mott, R Sutiwisesak , YJ Lu , F Raso - PLoS , 2018 - journals.plos.orghttps://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1007060 Antigen Specific CD4+ and CD8+ T Cell Recognition During Mycobacterium Tuberculosis Infection JD Yang - 2018 - repository.escholarship.umassmed https://repository.escholarship.umassmed.edu/handle/20.500.14038/32354 Differential influence of nutrient-starved Mycobacterium tuberculosis on adaptive immunity results in progressive tuberculosis disease and pathology J Dietrich , S Roy, I Rosenkrands - Infection and , 2015 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/iai.01055-15 Mycobacterium tuberculosis produces d-serine under hypoxia to limit CD8+ T cell-dependent immunity in mice H Cheng, Z Ji, Y Wang, S Li, T Tang, F Wang - Nature , 2024 - nature.comhttps://www.nature.com/articles/s41564-024-01701-1 Replication-Deficient Lymphocytic Choriomeningitis Virus-Vectored Vaccine Candidate for the Induction of T Cell Immunity against Mycobacterium tuberculosis E Belnoue, A Vogelzang, NE Nieuwenhuizen - International Journal of , 2022 - mdpi.comhttps://www.mdpi.com/1422-0067/23/5/2700 Human and murine clonal CD8+ T cell expansions arise during tuberculosis because of TCR selection CN Alves, MG Booty , SM Carpenter , AC Rothchild - 2015 - repositorium.sdum.uminho.pthttps://repositorium.sdum.uminho.pt/handle/1822/40054 Nanoscale Peptide Self-assemblies Boost BCG-primed Cellular Immunity Against Mycobacterium tuberculosis CB Chesson, M Huante, RJ Nusbaum , AG Walker - Scientific reports, 2018 - nature.comhttps://www.nature.com/articles/s41598-018-31089-y Mucosal BCG vaccination induces protective lung-resident memory T cell populations against tuberculosis C Perdomo, U Zedler, AA Kuhl, L Lozza, P Saikali - MBio, 2016 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/mbio.01686-16 Human and murine clonal CD8+ T cell expansions arise during tuberculosis because of TCR selection C Nunes-Alves, MG Booty , SM Carpenter - PLoS , 2015 - journals.plos.orghttps://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1004849

Avviso:
I nostri prodotti sono destinati esclusivamente ad uso di laboratorio. Per qualsiasi altro utilizzo, vi preghiamo di contattarci.
Marchio:
Biosynth
Conservazione lunga:
Note:

Proprietà chimiche

MDL:
Punto di fusione:
Punto di ebollizione:
Punto di infiammabilità:
Densità:
Concentrazione:
EINECS:
Merck:
Codice SA:

Informazioni sui pericoli

Numero ONU:
EQ:
Classe:
Indicazioni di pericolo:
Consigli di prudenza:
Vietato trasportare in aereo:
Informazioni sui pericoli:
Gruppo di imballaggio:
LQ:

Richiesta tecnica su: 3D-PP44770 H-IMYNYPAM-OH

Si prega di utilizzare piuttosto il carrello per richiedere un preventivo o un ordine

Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.

* Campi obbligatori
Benvenuto su CymitQuimica!Utilizziamo i cookie per migliorare la tua visita. Non includiamo pubblicità.

Consulta la nostra Politica sui Cookie per maggiori dettagli o regola le tue preferenze in "Configura".